Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China
· Delayed Price · Currency is CNY 4.230
-0.050 (-1.17%)
Jun 5, 2025, 2:45 PM CST
SHE:300194 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 278.17 | 231.87 | 204.61 | -296.91 | 209.37 | Upgrade
|
| Depreciation & Amortization | 198.63 | 208.74 | 184.43 | 174.29 | 155.78 | Upgrade
|
| Other Amortization | 0.59 | 1.04 | 0.97 | 0.7 | 0.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -220.65 | -4.85 | -0.31 | -1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 69.4 | 228.06 | 25.41 | 827.23 | 2.69 | Upgrade
|
| Loss (Gain) From Sale of Investments | -77.26 | -77.8 | -62.16 | -52.47 | -39.84 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.43 | 3.68 | 4.27 | -1.78 | Upgrade
|
| Other Operating Activities | 27.93 | 44.66 | 46.76 | -286.2 | 13.21 | Upgrade
|
| Change in Accounts Receivable | 46.84 | 71.85 | -78.5 | -68.26 | -75.1 | Upgrade
|
| Change in Inventory | -182.31 | 9.2 | -120.85 | -65.3 | -119.29 | Upgrade
|
| Change in Accounts Payable | -72.15 | -193.15 | 159.88 | 24.98 | 24.92 | Upgrade
|
| Change in Other Net Operating Assets | 10.07 | 4.8 | 4.4 | - | - | Upgrade
|
| Operating Cash Flow | 303.59 | 328.98 | 339.5 | 257.13 | 162.55 | Upgrade
|
| Operating Cash Flow Growth | -7.72% | -3.10% | 32.04% | 58.18% | -45.01% | Upgrade
|
| Capital Expenditures | -241.79 | -215.68 | -383.1 | -413.03 | -344.53 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.3 | 122.67 | 4.28 | 31.49 | 71.12 | Upgrade
|
| Cash Acquisitions | - | - | - | -1 | -201.16 | Upgrade
|
| Divestitures | - | - | -0.06 | - | - | Upgrade
|
| Investment in Securities | -25 | -1.25 | -71.43 | 32.38 | 52.23 | Upgrade
|
| Other Investing Activities | 1.66 | 0.64 | 10.31 | 0.94 | 105.51 | Upgrade
|
| Investing Cash Flow | -264.83 | -93.62 | -440.01 | -349.24 | -316.84 | Upgrade
|
| Short-Term Debt Issued | - | - | 49.28 | - | - | Upgrade
|
| Long-Term Debt Issued | 485.09 | 848.08 | 588.56 | 964.75 | 643.2 | Upgrade
|
| Total Debt Issued | 485.09 | 848.08 | 637.84 | 964.75 | 643.2 | Upgrade
|
| Long-Term Debt Repaid | -665.11 | -706.06 | -802.42 | -683 | -205.22 | Upgrade
|
| Total Debt Repaid | -665.11 | -706.06 | -802.42 | -683 | -205.22 | Upgrade
|
| Net Debt Issued (Repaid) | -180.02 | 142.02 | -164.58 | 281.75 | 437.98 | Upgrade
|
| Common Dividends Paid | -84.22 | -93.98 | -28.09 | -84.11 | -72.71 | Upgrade
|
| Other Financing Activities | 36.31 | -1.78 | 20.99 | 13.77 | -38.29 | Upgrade
|
| Financing Cash Flow | -227.93 | 46.25 | -171.68 | 211.41 | 326.98 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.91 | 0.88 | 2.91 | -2.17 | -13.73 | Upgrade
|
| Net Cash Flow | -188.26 | 282.49 | -269.27 | 117.13 | 158.97 | Upgrade
|
| Free Cash Flow | 61.8 | 113.3 | -43.6 | -155.91 | -181.98 | Upgrade
|
| Free Cash Flow Growth | -45.46% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 2.58% | 4.28% | -1.80% | -6.35% | -7.68% | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.09 | -0.04 | -0.13 | -0.16 | Upgrade
|
| Cash Income Tax Paid | 202.61 | 198.28 | 155.41 | 190.43 | 213.76 | Upgrade
|
| Levered Free Cash Flow | 14.37 | 98.2 | -60.74 | -139.3 | 46.66 | Upgrade
|
| Unlevered Free Cash Flow | 14.37 | 116.68 | -43.91 | -126.52 | 53.01 | Upgrade
|
| Change in Net Working Capital | 135.67 | -7.25 | -91.15 | -19.27 | -130.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.